First Time Loading...

Adaptimmune Therapeutics PLC
NASDAQ:ADAP

Watchlist Manager
Adaptimmune Therapeutics PLC Logo
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Watchlist
Price: 1.195 USD -3.63% Market Closed
Updated: May 16, 2024

EV/S
Enterprise Value to Sales

2.6
Current
8.8
Median
7.5
Industry
Lower than median
Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
2.6
=
Enterprise Value
158.5m
/
Revenue
60.3m
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
2.2
2-Years Forward
EV/S
2.4
3-Years Forward
EV/S
2.9

See Also

Discover More